South Africa
Industry
According to South Africa's Business Day, Discovery Health saved ZAR181mn (US$24mn) a year by cutting unnecessary hospital admissions. The firm saved ZAR434mn (US$57.37mn) by negotiating...
2008-07-23Industry
IRIN quoted Dr Clarence Mini of Africa Health Placements stating that South Africa's state hospitals are facing a shortage of more than 4,000 doctors.
2008-07-17Industry
Namibia is to follow South Africa's lead by rescheduling a number of medicines containing ephedrine, pseudoephedrine and d-norpseudoephedrine as prescription-only drugs. The new schedule...
2008-07-10Companies
South Africa's Department of Health has announced the awarding of contracts worth ZAR3.62bn (US$468.1mn) for its two-year HIV/AIDS tender, which will begin retrospectively from June...
2008-07-09Companies
Indian generics firm Zydus Cadila has announced that it is to acquire 70% of South Africa's Simayla Pharmaceuticals, as part of its drive to penetrate southern Africa's generics markets....
2008-06-10Companies
Merck Sharpe & Dohme (MSD), the international subsidiary of US-based Merck & Co has granted a further two licences for generic versions of its antiretroviral (ARV) Stocrin...
2008-06-05Companies
Old Mutual South Africa (OMSA) has signed a memorandum of understanding with Lethimvula Investments that would see the merger of their respective healthcare interests to form South...
2008-05-20Companies
Highlighting the legal minefield of bioprospecting, Germany's Schwabe Pharmaceuticals is facing a challenge to two European Patent Office (EPO) patents for its phytopharmaceutical...
2008-05-14Companies
In the company's own words, Enaleni's recently released annual results for the year ending December 31 2007 were 'reasonable, under the circumstances'. BMI would agree with this assessment....
2008-03-18Industry
South Africa was recently chastised for dragging its heels on the implementation of a World Health Organization (WHO)-recommended switch to dual-antiretroviral (ARV) treatment for...
2008-03-13




